Condition of the hemostatic system in pregnant women with the threat of premature birth when using metabolic therapy

Показати скорочений опис матеріалу

dc.contributor.author Panchuk, E. A.
dc.date.accessioned 2020-04-29T10:59:51Z
dc.date.available 2020-04-29T10:59:51Z
dc.date.issued 2019
dc.identifier.citation Panchuk E. A. Condition of the hemostatic system in pregnant women with the threat of premature birth when using metabolic therapy // Journal of Education, Health and Sport. 2019. Vol. 9 (1). P. 124–127. uk_UA
dc.identifier.uri https://repo.odmu.edu.ua:443/xmlui/handle/123456789/7011
dc.description.abstract 130 pregnant women were examined with the threat of premature birth in the gestational age of 28-34 weeks: I group – 67 pregnant women with threatened preterm labor who received standard complex therapy in combination with metabolic therapy in the form of 300 mg of omega-3 polyunsaturated fatty acidsper day, group II - 63 pregnant women with threatened preterm labor who received only standard complextherapy. Analyzing the state of the hemostasis system, the following changes were revealed: an increase in the level of fibrinogen and prothrombin time, indicating a hypercoagulative process.Were observed a decrease in fibrinogen level, an increase in platelet count and activated partial thromboplastin time and a decrease in prothrombin time after treatment with the use of metabolic therapy, indicating the antithrombotic and antiaggregatory effects of metabolic therapy. uk_UA
dc.language.iso en uk_UA
dc.subject preterm labor uk_UA
dc.subject hemostasis system uk_UA
dc.subject metabolic therapy uk_UA
dc.title Condition of the hemostatic system in pregnant women with the threat of premature birth when using metabolic therapy uk_UA
dc.type Article uk_UA


Долучені файли

Даний матеріал зустрічається у наступних зібраннях

Показати скорочений опис матеріалу